ANI Pharmaceuticals, Inc.ANIPNASDAQ
Loading
Debt to Equity Over TimeCompressed
Percentile Rank21
3Y CAGR-10.8%
5Y CAGR-8.7%
Studio
Year-over-Year Change

Debt-to-equity ratio

3Y CAGR
-10.8%/yr
vs -2.3%/yr prior
5Y CAGR
-8.7%/yr
Consistent
Acceleration
-8.5pp
Decelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive declineCompressed
PeriodValueYoY Change
20250.60-58.7%
20241.46+133.3%
20230.62-26.2%
20220.85+5.7%
20210.80-15.6%
20200.95+8.7%
20190.87-5.9%
20180.93-19.5%
20171.15+62.1%
20160.71-